Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc.

NASDAQ:PRAX

Overview | Financials
Company Name Praxis Precision Medicines, Inc.
Symbol PRAX
Currency USD
Price 37.2
Market Cap 750,074,760
Dividend Yield 0%
52-week-range 26.7 - 91.83
Industry Biotechnology
Sector Healthcare
CEO Mr. Marcio Souza M.B.A.
Website https://www.praxismedicines.com

An error occurred while fetching data.

About Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and

Related Stocks

Adicet Bio, Inc. logo

Adicet Bio, Inc.

ACET

0.622 USD

Vaxart, Inc. logo

Vaxart, Inc.

VXRT

0.425 USD

Kinnate Biopharma Inc. logo

Kinnate Biopharma Inc.

KNTE

2.65 USD

Rallybio Corporation logo

Rallybio Corporation

RLYB

0.304 USD

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

7.68 USD

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

DRTS

2.71 USD

IRadimed Corporation logo

IRadimed Corporation

IRMD

53.7 USD

RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc.

RAPT

0.906 USD

Nuvalent, Inc. logo

Nuvalent, Inc.

NUVL

75.87 USD

Financials

Numbers are in millions USD

Numbers are in millions USD